Ligand · T8W
T8W · 4-[[49,50,51,52,53,54,55,56-octahydroxy-11,17,23,29,35, 41,47-heptakis[(4-sulfonatophenyl)methyl]-5-nonacyclo[43.3.1.13,7.19,13.115,19.121,25.127,31.133, 37.139,43]hexapentaconta-1(49),3,5,7(56),9,11,13(55), 15,17,19(54),21,23,25(53),27,29,31(52),33,35,37(51), 39,41,43(50),45,47-tetracosaenyl]methyl]benzenesulfonate
T8W, 4-[[49,50,51,52,53,54,55,56-octahydroxy-11,17,23,29,35, 41,47-heptakis[(4-sulfonatophenyl)methyl]-5-nonacyclo[43.3.1.13,7.19,13.115,19.121,25.127,31.133, 37.139,43]hexapentaconta-1(49),3,5,7(56),9,11,13(55)…
- Component
- T8W
- Formula
- C112 H88 O32 S8 -8
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
T8W in 1 structure; the first of them:
- 7BBT · Structure of cytochrome C in complex with a P-benzyl-sulfonato- CALIX[8]ARENE-peg… · T8W C202 · binds LYS5, THR8, LYS11, THR12, LYS87, LYS5, THR8, LYS11 and 3 more
Residues it binds most
LYS 2, THR 3, ARG 2, GLN 1, ALA 1, LEU 1, SER 1 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.